{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:04:07Z","timestamp":1784178247821,"version":"3.55.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Severe\n                    <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                    pneumonia (SMPP) presents a major clinical challenge, increasingly complicated by macrolide-resistant strains (MRMP) and viral co-infections. The progression of SMPP is fundamentally driven by intricate immune-mediated mechanisms rather than direct pathogen-induced injury. Key drivers include innate immune hyperactivation, such as NLRP3 inflammasome-mediated pyroptosis, and adaptive immune dysregulation, characterized by the hyperactivation of pathogenic Th17 cells. Furthermore, systemic azithromycin administration can disrupt the gut-lung axis by depleting short-chain fatty acid (SCFA)-producing commensals, impairing regulatory T cell (Treg) generation, and exacerbating lung injury. Traditional diagnostics often struggle to predict severe disease; however, integrating multi-omics data and clinical biomarkers into machine-learning nomograms offers a more precise approach for identifying high-risk patients early. This precision risk stratification guides the deployment of targeted host-directed therapies (HDTs), including corticosteroids, small molecule inhibitors, anticoagulants, and early bronchoalveolar lavage. These interventions aim to dampen excessive inflammation, counteract hypercoagulability, and restore airway patency. This review summarizes the current understanding of SMPP and proposes a translational framework combining advanced diagnostics with targeted interventions to optimize clinical outcomes.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1833802","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:43Z","timestamp":1784175703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunopathogenesis, molecular phenotyping, and host-directed interventions for severe pediatric Mycoplasma pneumoniae pneumonia in the post-pandemic era"],"prefix":"10.3389","volume":"16","author":[{"given":"Fu","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Guangyuan Central Hospital","place":["Guangyuan, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112184","article-title":"Il-17 stimulates neutrophils to release S100A8\/A9 to promote lung epithelial cell apoptosis in Mycoplasma pneumoniae-induced pneumonia in children","volume":"143","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v14.i4.108047","article-title":"Comprehensive study of community acquired Mycoplasma pneumoniae pneumonia in children in Baoding, Chin","volume":"14","author":"Bi","year":"2025","journal-title":"World J. Clin. Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/inf.0000000000004568","article-title":"Treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children: A meta-analysis of macrolides versus tetracyclines","volume":"44","author":"Bolormaa","year":"2025","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"qiaf163","DOI":"10.1093\/jleuko\/qiaf163","article-title":"Knocking down ABCG1 activates NLRP3\/Caspase-1 pathway to promote neutrophil pyroptosis and exacerbate Mycoplasma pneumoniae pneumonia in children","volume":"117","author":"Cai","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1002\/ppul.26691","article-title":"Pulmonary embolism associated with Mycoplasma pneumoniae pneumonia in children","volume":"58","author":"Chen","year":"2023","journal-title":"Pediatr. Pulmonol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2147\/idr.S466994","article-title":"Azithromycin effectiveness in children with mutated Mycoplasma pneumoniae pneumonia","volume":"17","author":"Cheng","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1002\/ppul.25665","article-title":"Mycoplasma pneumoniae infection prediction model for hospitalized community-acquired pneumonia children","volume":"56","author":"Chen","year":"2021","journal-title":"Pediatr. Pulmonol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/phmt.S473669","article-title":"Surge in Mycoplasma pneumoniae infection and respiratory viruses co-infection in children with community-acquired pneumonia in the post-pandemic","volume":"15","author":"Chi","year":"2024","journal-title":"Pediatr. Health Med. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3760\/cma.j.cn112137-20251021-02702","article-title":"Clinical practice guideline for the use of new-generation tetracycline-class antibiotics in pediatrics, (2026 edition)","volume":"106","year":"2026","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/jcpt.13331","article-title":"The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"46","author":"Dai","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1763133","article-title":"Research advances in pathogenic mechanisms and host response of mycoplasma pneumoniae pneumonia in children: a metabolomics perspective","volume":"13","author":"Dai","year":"2026","journal-title":"Front. Med. (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2323\/jgam.2022.05.004","article-title":"16S rRNA gene sequencing reveals an altered composition of gut microbiota in children with Mycoplasma pneumoniae pneumonia treated with azithromycin","volume":"68","author":"Deng","year":"2023","journal-title":"J. Gen. Appl. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1542\/hpeds.2020-005215","article-title":"Mycoplasma pneumoniae testing and treatment among children with community-acquired pneumonia","volume":"11","author":"Desai","year":"2021","journal-title":"Hosp. Pediatr."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202567065","article-title":"Role of the Notch ligand DLL4 in the immune response of children with Mycoplasma pneumoniae pneumonia","volume":"67","author":"Dong","year":"2025","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1482880","article-title":"Co-detection of respiratory pathogens in children with Mycoplasma pneumoniae pneumonia: a multicenter study","volume":"13","author":"Dong","year":"2025","journal-title":"Front. Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/00099228251392096","article-title":"Increased macrolide-resistant Mycoplasma pneumoniae infections and response to doxycycline in Midwest United States","volume":"65","author":"Douvoyiannis","year":"2026","journal-title":"Clin. Pediatr. (Phila)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00137-26","article-title":"Modeling chronic infection with Mycoplasma pneumoniae at an air-liquid interface: global transcriptional response of HBEC3-KT respiratory epithelial cells to biofilm towers","volume":"94","author":"Fahim","year":"2026","journal-title":"Infect. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10096-024-04854-3","article-title":"Risk factors for pneumonia among children with coinfection of influenza A virus and Mycoplasma pneumoniae","volume":"43","author":"Fu","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7499\/j.issn.1008-8830.2203030","article-title":"Value of autotaxin in predicting refractory Mycoplasma pneumoniae pneumonia in children and its correlation with inflammatory cytokines","volume":"24","author":"Fu","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jcu.23678","article-title":"Quantitative evaluation of bronchoalveolar lavage for the treatment of severe Mycoplasma pneumoniae pneumonia in children-a new complementary index: bronchial insufflation sign score","volume":"52","author":"Gao","year":"2024","journal-title":"J. Clin. Ultrasound"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024894","article-title":"The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis","volume":"100","author":"Gong","year":"2021","journal-title":"Med. (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-10-30","article-title":"Beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells","volume":"10","author":"Gross","year":"2010","journal-title":"BMC Pulm. Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111474","article-title":"Risk factors for suspected pulmonary embolism in children: complication of Mycoplasma pneumoniae pneumonia","volume":"176","author":"Gu","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.71046","article-title":"Development and evaluation of a nomogram for predicting pulmonary embolism in children with severe Mycoplasma pneumoniae pneumonia","volume":"60","author":"Guan","year":"2025","journal-title":"Pediatr. Pulmonol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.62347\/oupw3987","article-title":"Clinical value of monitoring cytokine levels for assessing the severity of mycoplasma pneumoniae pneumonia in children","volume":"16","author":"Han","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1128\/iai.01989-14","article-title":"Mycoplasma pneumoniae modulates STAT3-STAT6\/EGFR-FOXA2 signaling to induce overexpression of airway mucins","volume":"82","author":"Hao","year":"2014","journal-title":"Infect. Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1038\/s41598-025-92089-3","article-title":"Development of machine learning-based differential diagnosis model and risk prediction model of organ damage for severe Mycoplasma pneumoniae pneumonia in children","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/ppul.26426","article-title":"Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia","volume":"58","author":"He","year":"2023","journal-title":"Pediatr. Pulmonol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1038\/s41598-025-88418-1","article-title":"Chest CT characterization of children with necrotizing pneumonia due to Mycoplasma pneumoniae infection","volume":"15","author":"Hou","year":"2025","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1186\/s12879-025-11405-4","article-title":"Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3892\/mmr.2021.12401","article-title":"Ribosomal RNA-depleted RNA sequencing reveals the pathogenesis of refractory Mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7499\/j.issn.1008-8830.2012095","article-title":"Value of chitinase-like protein YKL-40 in bronchoalveolar lavage fluid for predicting refractory Mycoplasma pneumoniae pneumonia in children","volume":"23","author":"Huang","year":"2021","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00431-026-06802-z","article-title":"Prevalence, risk factors, and early prediction of refractory pneumonia caused by Mycoplasma pneumoniae in children: a systematic review and meta-analysis","volume":"185","author":"Huang","year":"2026","journal-title":"Eur. J. Pediatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2200455","DOI":"10.1183\/13993003.00455-2022","article-title":"Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding","volume":"60","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12931-025-03189-7","article-title":"Immunological landscape of children with Mycoplasma pneumoniae pneumonia in the post-COVID-19 era reveals distinctive severity indicators","volume":"26","author":"Jia","year":"2025","journal-title":"Respir. Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108497","article-title":"Lung ultrasound score: a strong predictor of severe Mycoplasma pneumoniae pneumonia in children","volume":"250","author":"Jia","year":"2025","journal-title":"Respir. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10096-024-04834-7","article-title":"Development and validation of an online dynamic nomogram system for pulmonary consolidation in children with Mycoplasma pneumoniae pneumonia","volume":"43","author":"Jia","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00103-25","article-title":"The predictive value of MUC5AC levels in the sputum of children with Mycoplasma pneumoniae pneumonia treated with fiberbronchoscopy","volume":"13","author":"Jian","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.21037\/tp-24-172","article-title":"Predictive value of immune-related parameters in severe Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Jiang","year":"2024","journal-title":"Transl. Pediatr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12879-025-10712-0","article-title":"Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023-February 2024","volume":"25","author":"Korneenko","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/biom14101263","article-title":"Mechanistic insights into clinically relevant ribosome-targeting antibiotics","volume":"14","author":"Krawczyk","year":"2024","journal-title":"Biomolecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jmii.2021.09.010","article-title":"The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan 2019-2020","volume":"55","author":"Kuo","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jmii.2021.08.010","article-title":"A potent antibody-secreting B cell response to Mycoplasma pneumoniae in children with pneumonia","volume":"55","author":"Lai","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/microorganisms12091806","article-title":"Clinical manifestations, macrolide resistance, and treatment utilization trends of Mycoplasma pneumoniae pneumonia in children and adolescents in South Korea","volume":"12","author":"Lee","year":"2024","journal-title":"Microorganisms"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1985531","article-title":"Diagnosis and prognostic analysis of Mycoplasma pneumoniae pneumonia in children based on high-resolution computed tomography","volume":"2022","author":"Leng","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"key":"B46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1186\/s12879-021-06632-4","article-title":"Serum CXCL10\/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1676950","article-title":"Serum vitamins and Mycoplasma pneumoniae pneumonia in children: a case-control study","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.9234","article-title":"Biomarkers of Mycoplasma pneumoniae pneumonia in children by urine metabolomics based on Q Exactive liquid chromatography\/tandem mass spectrometry","volume":"36","author":"Li","year":"2022","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"B49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13052-025-01879-y","article-title":"Effect of bronchofiberscopic lavage with acetylcysteine instillation on refractory mycoplasma pneumoniae pneumonia in children: a retrospective clinical observation","volume":"51","author":"Li","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0341580","article-title":"Association analysis of Mycoplasma pneumoniae 23S rRNA gene mutation with refractory Mycoplasma pneumoniae pneumonia in children","volume":"21","author":"Li","year":"2026","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.7754\/Clin.Lab.2022.220339","article-title":"Clinical efficacy and immune function of andrographolide sulfonate in children with Mycoplasma pneumoniae pneumonia","volume":"69","author":"Li","year":"2023","journal-title":"Clin. Lab."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102748","article-title":"Molecular characteristics of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Urumqi, Xinjiang, China in autumn, winter, and spring 2023-2024","volume":"18","author":"Li","year":"2025","journal-title":"J. Infect. Public Health"},{"key":"B53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12887-023-04512-1","article-title":"Clinical features of Mycoplasma pneumoniae pneumonia in children without fever","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pediatr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13052-023-01545-1","article-title":"Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity","volume":"49","author":"Li","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"B55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13052-025-02006-7","article-title":"Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia","volume":"51","author":"Li","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3760\/cma.j.cn112150-20240909-00721","article-title":"Characteristics of peripheral blood lymphocyte subsets in children with mycoplasma pneumoniae pneumonia under different infection states","volume":"59","author":"Li","year":"2025","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1038\/s41598-025-32941-8","article-title":"A prediction model for bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and consolidation","volume":"16","author":"Liang","year":"2026","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03261","article-title":"Role of probiotics in Mycoplasma pneumoniae pneumonia in children: a short-term pilot project","volume":"9","author":"Ling","year":"2018","journal-title":"Front. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17164","article-title":"Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study","volume":"12","author":"Liu","year":"2024","journal-title":"PeerJ"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211021733","article-title":"Prevalence and clinical characteristics of septicemia in children with Mycoplasma pneumoniae pneumonia","volume":"49","author":"Liu","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13052-025-02039-y","article-title":"Prediction model for severe mycoplasma pneumoniae pneumonia and analysis of macrolide-resistance in children: a case-control study","volume":"51","author":"Liu","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"piaf075","DOI":"10.1093\/jpids\/piaf075","article-title":"Empiric antibiotic therapy for Mycoplasma pneumoniae pneumonia in children: a pro\/con discussion","volume":"14","author":"Lloyd","year":"2025","journal-title":"J. Pediatr. Infect. Dis. Soc"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111503","article-title":"Risk factors and prescription patterns analysis for macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"27","author":"Lu","year":"2024","journal-title":"iScience"},{"key":"B64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-024-02996-w","article-title":"Predictive value of bronchoscopy combined with CT score for refractory mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Lu","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"22811","DOI":"10.1038\/s41598-025-05548-2","article-title":"Establishment and validation of a predictive model for lobar pneumonia caused by Mycoplasma pneumoniae infection in children","volume":"15","author":"Luo","year":"2025","journal-title":"Sci. Rep."},{"key":"B66","first-page":"251","article-title":"Epidemiological characteristics and related risk factors of mixed infection in children with mycoplasma pneumoniae pneumonia","volume":"47","author":"Lv","year":"2024","journal-title":"New Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"fuae007","DOI":"10.1093\/femsre\/fuae007","article-title":"In vitro modelling of bacterial pneumonia: a comparative analysis of widely applied complex cell culture models","volume":"48","author":"Mahieu","year":"2024","journal-title":"FEMS Microbiol. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s13063-024-08438-6","article-title":"A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study","volume":"25","author":"Meyer Sauteur","year":"2024","journal-title":"Trials"},{"key":"B69","doi-asserted-by":"publisher","first-page":"31406","DOI":"10.1038\/s41598-025-15333-w","article-title":"Combining circ_0054633 and clinical features to predict refractory Mycoplasma pneumoniae pneumonia in children","volume":"15","author":"Mu","year":"2025","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12938-025-01410-8","article-title":"Prediction of risk factors of plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia","volume":"24","author":"Mu","year":"2025","journal-title":"Biomed. Eng. Online"},{"key":"B71","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3760\/cma.j.cn112140-20240417-00272","article-title":"Clinical characteristics and predictive factors for plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia","volume":"62","author":"Mu","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B72","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12879-025-11132-w","article-title":"Predicting myocardial damage in children with mycoplasma pneumoniae pneumonia: a retrospective case-control study","volume":"25","author":"Ni","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1093\/infdis\/jiad573","article-title":"Combinatorial host-response biomarker signature (BV score) and its subanalytes TRAIL, IP-10, and C-reactive protein in children with Mycoplasma pneumoniae community-acquired pneumonia","volume":"230","author":"Papan","year":"2024","journal-title":"J. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s10096-025-05194-6","article-title":"Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia","volume":"44","author":"Piao","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/iai.01036-13","article-title":"In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium","volume":"82","author":"Prince","year":"2014","journal-title":"Infect. Immun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ped4.12469","article-title":"Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children, (2023)","volume":"9","year":"2025","journal-title":"Pediatr. Investig."},{"key":"B77","doi-asserted-by":"publisher","first-page":"001910","DOI":"10.1099\/jmm.0.001910","article-title":"Mycoplasma pneumoniae: not a typical respiratory pathogen","volume":"73","author":"Rowlands","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12887-024-05150-x","article-title":"Efficacy of azithromycin combined with intravenous immunoglobulin in the treatment of refractory mycoplasma pneumoniae pneumonia in children: a meta-analysis","volume":"24","author":"Shen","year":"2024","journal-title":"BMC Pediatr."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2026.1762614","article-title":"Direct hospitalization costs of children with Mycoplasma pneumoniae pneumonia from 2013 to 2025 in China: a longitudinal retrospective single-center study","volume":"14","author":"Shen","year":"2026","journal-title":"Front. Public Health"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.21037\/tp-24-16","article-title":"Construction of a nomogram for early diagnosis of refractory Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Shen","year":"2024","journal-title":"Transl. Pediatr."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12879-025-11584-0","article-title":"Clinical characteristics of mycoplasma pneumoniae pneumonia in children with 23 S rRNA mutations in domain V and exploration of the timing of glucocorticoid therapy","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12879-024-09564-x","article-title":"Azithromycin sequential therapy plus inhaled terbutaline for Mycoplasma Pneumoniae pneumonia in children: a systematic review and meta-analysis","volume":"24","author":"Sheng","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2414805","article-title":"The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease","volume":"16","author":"Song","year":"2024","journal-title":"Gut Microbes"},{"key":"B85","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12887-023-04188-7","article-title":"A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia","volume":"23","author":"Song","year":"2023","journal-title":"BMC Pediatr."},{"key":"B86","first-page":"78","article-title":"Children with acute respiratory distress syndrome and refractory pneumonia caused by Mycoplasma pneumoniae","volume":"48","author":"Tang","year":"2025","journal-title":"New Microbiol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1703027","article-title":"Pulmonary embolism complicating Mycoplasma pneumoniae pneumonia in children: a retrospective case series","volume":"13","author":"Tao","year":"2025","journal-title":"Front. Pediatr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","article-title":"Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Tsai","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B89","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12879-023-08161-8","article-title":"Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study","volume":"23","author":"Tuo","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/microorganisms13040883","article-title":"Characteristics of Mycoplasma pneumoniae pneumonia in Romanian children","volume":"13","author":"Ulmeanu","year":"2025","journal-title":"Microorganisms"},{"key":"B91","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/nu15030486","article-title":"Microbiome and asthma: microbial dysbiosis and the origins, phenotypes, persistence, and severity of asthma","volume":"15","author":"Valverde-Molina","year":"2023","journal-title":"Nutrients"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","article-title":"Developmental changes in pharmacokinetics and pharmacodynamics","author":"Van Den Anker","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jped.2023.06.004","article-title":"Clinical significance of serum microRNA-146a and inflammatory factors in children with Mycoplasma pneumoniae pneumonia after azithromycin treatment","volume":"100","author":"Wang","year":"2024","journal-title":"J. Pediatr. (Rio J)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13052-023-01500-0","article-title":"Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value","volume":"49","author":"Wang","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153136","article-title":"Dual-phase study of CD4(+)CXCR4(+) T cells in Mycoplasma pneumoniae pneumonia: clinical correlations in children and therapeutic exploration with tofacitinib in mice","volume":"230","author":"Wang","year":"2025","journal-title":"Immunobiology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2147\/idr.S459626","article-title":"Characteristics and outcomes of Mycoplasma Pneumoniae pneumonia associated with pulmonary embolism and necrotizing pneumonia in children","volume":"17","author":"Wang","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"B97","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/13860291251313591","article-title":"Correlation between changes in haemorheology and the HIF-1\/EPO pathway in children with Mycoplasma pneumoniae pneumonia","volume":"89","author":"Wang","year":"2025","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/ppul.27120","article-title":"Oxidative stress in the alveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia","volume":"59","author":"Wang","year":"2024","journal-title":"Pediatr. Pulmonol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.12182\/20251160504","article-title":"Clinical study of different doses of glucocorticoids in the treatment of severe Mycoplasma pneumoniae pneumonia in children","volume":"56","author":"Wang","year":"2025","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8085530","article-title":"Chest CT findings and differential diagnosis of Mycoplasma pneumoniae pneumonia and Mycoplasma pneumoniae combined with streptococcal pneumonia in children","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Healthc Eng."},{"key":"B101","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41390-021-01874-z","article-title":"The role of flexible bronchoscopy in children with Mycoplasma pneumoniae pneumonia","volume":"93","author":"Wang","year":"2023","journal-title":"Pediatr. Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3760\/cma.j.cn112140-20231227-00466","article-title":"Clinical phenotyping of severe Mycoplasma pneumoniae pneumonia in children","volume":"62","author":"Wang","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.7499\/j.issn.1008-8830.2305113","article-title":"Construction of a predictive model for performing bronchoalveolar lavage in children with Mycoplasma pneumoniae pneumonia and pulmonary consolidation","volume":"25","author":"Wang","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B104","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","article-title":"Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"20","author":"Wang","year":"2024","journal-title":"World J. Pediatr."},{"key":"B105","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12931-024-02892-1","article-title":"The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia","volume":"25","author":"Wei","year":"2024","journal-title":"Respir. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12879-023-08619-9","article-title":"Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3760\/cma.j.cn112150-20240606-00452","article-title":"A retrospective cohort study based on propensity score matching evaluated the effect of bronchoalveolar lavage on the clinical prognosis of children with macrolide drug-resistant Mycoplasma pneumoniae pneumonia","volume":"58","author":"Wu","year":"2024","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1438777","article-title":"Characteristics of lower respiratory microbiota in children's refractory Mycoplasma pneumoniae pneumonia pre- and post-COVID-19 era","volume":"14","author":"Xi","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"30758","DOI":"10.1038\/s41598-024-80906-0","article-title":"Construction and validation of a nomogram model to predict bronchiolitis Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Xiong","year":"2024","journal-title":"Sci. Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","article-title":"Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan 2020-2022","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Microbiol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100361","article-title":"Diagnostic values of soluble triggering receptor expressed on myeloid cells (sTREM-1) and interferon-inducible protein-10 (IP-10) for severe mycoplasma pneumoniae pneumonia in children","volume":"79","author":"Xu","year":"2024","journal-title":"Clinics (Sao Paulo)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.15586\/aei.v52i6.1184","article-title":"Effect of electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide on the efficacy of Mycoplasma pneumoniae pneumonia in children","volume":"52","author":"Xu","year":"2024","journal-title":"Allergol Immunopathol. (Madr)"},{"key":"B113","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3345\/kjp.2018.07367","article-title":"Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children","volume":"62","author":"Yang","year":"2019","journal-title":"Korean J. Pediatr."},{"key":"B114","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","article-title":"A comparative study of general and severe mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12879-025-10958-8","article-title":"A machine learning model for predicting severe mycoplasma pneumoniae pneumonia in school-aged children","volume":"25","author":"Ye","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jped.2020.11.004","article-title":"The critical function of miR-1323\/Il6 axis in children with Mycoplasma pneumoniae pneumonia","volume":"97","author":"Yin","year":"2021","journal-title":"J. Pediatr. (Rio J)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.21037\/jtd.2017.09.75","article-title":"Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study","volume":"9","author":"Yin","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13052-025-02105-5","article-title":"Serum expression of ESM-1 and Syndecan-1 and its relationship with disease severity in children with Mycoplasma pneumoniae pneumonia","volume":"51","author":"Yu","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"B119","doi-asserted-by":"publisher","first-page":"259","DOI":"10.23736\/s2724-5276.23.07158-6","article-title":"Cytokines and refractory mycoplasma pneumoniae pneumonia in children: a systematic review","volume":"76","author":"Yu","year":"2024","journal-title":"Minerva Pediatr. (Torino)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1604253","article-title":"D-dimer serves as predictor of plastic bronchitis or necrotizing pneumonia in children with Mycoplasma pneumoniae pneumonia","volume":"13","author":"Yue","year":"2025","journal-title":"Front. Pediatr."},{"key":"B121","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","article-title":"Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia","volume":"48","author":"Zhan","year":"2022","journal-title":"Ital. J. Pediatr."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106642","article-title":"Exhausted KLRG1(hi) CD8(+) T and pathogenic GZMA(+) Th17 cells are associated with the mild Mycoplasma pneumoniae pneumonia in children","volume":"91","author":"Zhan","year":"2025","journal-title":"J. Infect."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.741663","article-title":"Case report: Clinical analysis of fulminant Mycoplasma pneumoniae pneumonia in children","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Pediatr."},{"key":"B124","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-023-00793-9","article-title":"Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen","volume":"20","author":"Zhang","year":"2024","journal-title":"World J. Pediatr"},{"key":"B125","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3760\/cma.j.cn112140-20241202-00881","article-title":"Clinical characteristics and therapeutic experience with rivaroxaban in children with Mycoplasma pneumoniae pneumonia associated with pulmonary thromboembolism","volume":"63","author":"Zhang","year":"2025","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B126","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13052-024-01709-7","article-title":"Changes in urinary renal injury markers in children with Mycoplasma pneumoniae pneumonia and a prediction model for related early renal injury","volume":"50","author":"Zhang","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"24043","DOI":"10.1038\/s41598-024-74302-x","article-title":"Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-024-58784-3","article-title":"A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00431-022-04761-9","article-title":"Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model","volume":"182","author":"Zhang","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321454","article-title":"Use peripheral blood leukocyte parameters combined with inflammatory indicators in diagnosis and severity assessment of mycoplasma pneumoniae pneumonia in children","volume":"20","author":"Zhang","year":"2025","journal-title":"PloS One"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.687391","article-title":"The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"33","DOI":"10.29271\/jcpsp.2022.01.33","article-title":"Effect of methylprednisolone plus azithromycin on fractional exhaled nitric oxide and peripheral blood eosinophils in children with refractory Mycoplasma pneumoniae pneumonia","volume":"32","author":"Zhou","year":"2022","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7065890","article-title":"Characteristics of lung microbiota in children's refractory Mycoplasma pneumoniae pneumonia coinfected with human adenovirus B","author":"Zhou","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"716","DOI":"10.7499\/j.issn.1008-8830.2401076","article-title":"Value of calprotectin S100 A8\/A9 in predicting the severity of Mycoplasma pneumoniae pneumonia in children","volume":"26","author":"Zhou","year":"2024","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-directed therapies for infectious diseases: current status, recent progress, and future prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1833802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:54Z","timestamp":1784175714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1833802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":135,"alternative-id":["10.3389\/fcimb.2026.1833802"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1833802","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1833802"}}